SG89492G - A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride - Google Patents

A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride

Info

Publication number
SG89492G
SG89492G SG894/92A SG89492A SG89492G SG 89492 G SG89492 G SG 89492G SG 894/92 A SG894/92 A SG 894/92A SG 89492 A SG89492 A SG 89492A SG 89492 G SG89492 G SG 89492G
Authority
SG
Singapore
Prior art keywords
phenylmethyl
dihydrochloride
piperazinyl
chlorophenyl
ethoxy
Prior art date
Application number
SG894/92A
Other languages
English (en)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of SG89492G publication Critical patent/SG89492G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG894/92A 1988-11-23 1992-09-05 A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride SG89492G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827391A GB8827391D0 (en) 1988-11-23 1988-11-23 Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride

Publications (1)

Publication Number Publication Date
SG89492G true SG89492G (en) 1992-12-04

Family

ID=10647347

Family Applications (1)

Application Number Title Priority Date Filing Date
SG894/92A SG89492G (en) 1988-11-23 1992-09-05 A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride

Country Status (16)

Country Link
KR (1) KR970009728B1 (es)
AT (1) AT398971B (es)
CA (1) CA1317300C (es)
CY (1) CY1671A (es)
DK (1) DK174543B1 (es)
ES (1) ES2021907A6 (es)
FI (1) FI91862C (es)
GB (2) GB8827391D0 (es)
GR (1) GR1000553B (es)
HK (1) HK95892A (es)
HU (1) HU205094B (es)
NO (1) NO172342C (es)
PH (1) PH25982A (es)
PL (1) PL161379B1 (es)
PT (1) PT92364B (es)
SG (1) SG89492G (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703690B2 (en) * 1992-09-24 1999-04-01 Sepracor, Inc. Methods for treating allergic disorders using optically pure (+)cetirizine
AU5136193A (en) * 1992-09-24 1994-04-12 Sepracor, Inc. Methods and compositions for treating allergic disorders using optically pure (+) cetirizine
DE10199031I2 (de) * 1992-09-24 2004-09-23 Sepracor Inc Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma.
GB9305282D0 (en) * 1993-03-15 1993-05-05 Ucb Sa Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.
WO1998055459A1 (en) 1997-06-04 1998-12-10 Azwell Inc. Process for producing piperazinesulfonamide derivatives and salts thereof
EP0919550A1 (en) * 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
IL124195A (en) * 1998-04-23 2000-08-31 Chemagis Ltd Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid
GR990100135A (el) * 1999-04-22 2000-12-29 Genepharm �.�. Μεθοδος παρασκευης του 2-(2-[4-[4-χλωροφαινυλο)(φαινυλο)μεθυλο]πιπεραζινο]αιθοξυ) οξικου οξεος και του διυδροχλωρικου αλατος αυτου
JP2002249487A (ja) * 2001-02-22 2002-09-06 Sumitomo Chem Co Ltd 4−(tert−ブトキシカルボニル)ピペラジン誘導体、その光学活性な酸付加塩、それらの製造法、およびそれらを用いる光学活性な1−[(置換フェニル)フェニルメチル]ピペラジンの製造法。
US6977301B1 (en) 2001-05-29 2005-12-20 Ucb, S.A. Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
US7199241B1 (en) 2001-05-29 2007-04-03 Ucb, S.A. Process for preparing (S) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide
CA2514145A1 (en) 2003-01-23 2004-08-05 Ucb Farchim Sa Piperazine derivatives and their use as synthesis intermediates
KR100503443B1 (ko) 2004-02-02 2005-07-22 한림제약(주) 광학적으로 활성인 세티리진 또는 그의 염의 제조방법
ES2326689T3 (es) * 2005-03-03 2009-10-16 Ucb Farchim, S.A. Sales de piroglutamato y su uso en la resolucion optica de intermedios para la sintesis de dextrocetirizana y levocetirizana.
HU227325B1 (en) * 2005-12-08 2011-03-28 Egis Gyogyszergyar Nyrt Process for the production of an intermediate of (dextro- and levo)- cetirizine
SI22489A (sl) * 2007-03-12 2008-10-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek za pripravo levocetirizina in njegovih intermediatov
WO2008110586A2 (en) 2007-03-12 2008-09-18 Krka, Tovarna Zdravil, D.D., Novo Mesto New process for the preparation of levocetirizine and intermediates thereof
EP2167479B1 (en) 2007-06-15 2013-09-11 Symed Labs Limited Process for preparation of substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine using novel intermediates
WO2009062036A2 (en) * 2007-11-09 2009-05-14 Dr. Reddy's Laboratories Ltd. Processes for preparing levocetirizine and pharmaceutically acceptable salts thereof
ES2361343T3 (es) 2007-11-21 2011-06-16 Synthon B.V. Procedimiento para obtener n-(difenilmetil)piperazinas.
US7989623B2 (en) 2007-11-21 2011-08-02 Synthon Bv Process for making n-(diphenylmethyl)piperazines
KR20110022635A (ko) 2008-06-02 2011-03-07 시플라 리미티드 레보세티리진의 합성방법 및 이에 사용하기 위한 중간체
WO2009150147A1 (en) * 2008-06-11 2009-12-17 Krka, Tovarna Zdravil, D.D., Novo Mesto New process for the preparation of levocetirizine and intermediates thereof
KR100998067B1 (ko) 2008-09-08 2010-12-03 주식회사 삼오제약 비스(1-[(4-클로로페닐)페닐메틸]피페라진)-2,3-디벤조일 타르타르산 신규 중간체 염 및 이를 이용한 광학 활성적으로 순수한 1-[(4-클로로페닐)페닐메틸]피페라진을 분리하는 분리방법
WO2010046908A2 (en) 2008-09-17 2010-04-29 Calyx Chemicals And Pharmaceuticals Pvt. Ltd. Novel water based process for the preparation of substituted diphenylmethyl piperazines
WO2010107404A1 (en) 2009-03-16 2010-09-23 Mahmut Bilgic Stable pharmaceutical combinations
TR201007652A2 (tr) 2010-09-20 2012-04-24 Bi̇lgi̇ç Mahmut Sinerjik etki.
TR201009398A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Fiziksel özellikleri geliştirilmiş tablet formülasyonları
WO2012101475A1 (en) 2011-01-27 2012-08-02 Jubilant Life Sciences Limited An improved process for the preparation of antihistaminic drugs via a novel carbamate intermediate
CN103044355A (zh) * 2011-10-13 2013-04-17 湖南九典制药有限公司 合成左西替利嗪的关键中间体及其制备方法
KR101418404B1 (ko) 2012-01-06 2014-07-10 한미약품 주식회사 레보세티리진 또는 이의 약학적으로 허용가능한 염 및 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 함유하는 안정한 경구투여용 약학 제제
KR102226833B1 (ko) 2013-06-28 2021-03-12 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성이 개선된 복합 과립 제형
CN104045607B (zh) * 2014-05-21 2016-04-13 丽珠医药集团股份有限公司 一种盐酸西替利嗪的纯化方法
CN105924409B (zh) * 2016-05-12 2019-01-08 浙江永宁药业股份有限公司 一种(r)-1-((2-氯苯基)-(苯基)-甲基)-哌嗪的拆分方法
CN111205247B (zh) * 2020-04-22 2020-08-14 湖南九典宏阳制药有限公司 左旋西替利嗪的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf

Also Published As

Publication number Publication date
FI91862C (fi) 1994-08-25
DK174543B1 (da) 2003-05-19
FI895564A0 (fi) 1989-11-22
NO172342B (no) 1993-03-29
CA1317300C (en) 1993-05-04
NO894651D0 (no) 1989-11-22
DK586789A (da) 1990-05-24
GB2225321A (en) 1990-05-30
FI91862B (fi) 1994-05-13
GB2225321B (en) 1992-04-08
AT398971B (de) 1995-02-27
CY1671A (en) 1993-05-14
GB8926243D0 (en) 1990-01-10
PL161379B1 (pl) 1993-06-30
HUT53627A (en) 1990-11-28
PT92364B (pt) 1995-07-18
HU896131D0 (en) 1990-02-28
PH25982A (en) 1992-01-13
HK95892A (en) 1992-12-11
GR1000553B (el) 1992-08-26
PT92364A (pt) 1990-05-31
GB8827391D0 (en) 1988-12-29
DK586789D0 (da) 1989-11-22
NO172342C (no) 1993-07-07
HU205094B (en) 1992-03-30
GR890100770A (en) 1990-12-31
ATA266589A (de) 1994-07-15
ES2021907A6 (es) 1991-11-16
KR970009728B1 (ko) 1997-06-17
KR900007825A (ko) 1990-06-02
NO894651L (no) 1990-05-25

Similar Documents

Publication Publication Date Title
GB2225321B (en) A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride
GB2225320B (en) A process for the preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-acetic acid and its dihydrochloride
PL294704A1 (en) Method of obtaining 4-(2-(2-hydroxy-2-phenylethylamine)ethoxy) phenyloacetic acid and its bioprecursor substances
NO168771C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 11-(4-(2-(2-hydroksyetoksy)etyl)-1-piperazinyl)dibenzo(b,f)-(1,4)-tiazepin og farmasoeytisk akseptable salter derav
SI0955295T1 (en) Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl) piperazines
HU9700744D0 (en) Process for the manufacture of 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]-ethoxy]-acetic acid and its salts
DK164364C (da) 4-(isoxazolyl)-thiazol-2-oxaminsyreforbindelser, en fremgangsmaade til fremstilling heraf, et mellemprodukt til brug ved fremgangsmaaden samt et farmaceutisk praeparat
JPS57149282A (en) 2-(4-(diphenylmethyl)-1-piperazinyl)acetic acid and their derivatives as medicine
PL287224A1 (en) Method of obtaining 2-(2-(4-(/4-chlorophenyl/phenylmethyl)-1-piperazinyl) ethoxy) acetic acid and its dihydrohloride
HUP9901337A3 (en) A process for the preparation of esters of [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid
JPS6447776A (en) 1-(2-(phenylmethyl)phenyl)piperazine compound, manufacture and medicinal composition
AR242790A1 (es) Procedimiento para la preparacion de un derivado 4-(2-piridinil)-1-piperazinil-heterocilil carbonilico.
DE3165040D1 (en) 2-(2-amino-thiazol-4-yl)-n-(imidazolidin and perhydro-1,3-diazin-2-on-1-yl)-2-iminoacetylcephalosporins of the syn-form, and process for their preparation
IE870556L (en) 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl¹derivatives
IE890765L (en) New uses of 4-(3-phosphono-2-propenyl)-2-piperazinecarboxylic acid
CS224688A1 (en) 2-(biphenyl-4-yl)-5-phenyl-1,3,4-oxadiazole-4-carboxyl acid and its salts and method of their production
CS8904695A2 (en) Method of 2-(4-(2-(1-piperidinyl)-ethoxyl benzoyl) benzoic acid's 1-(4-amino-oxo-3,3-difenylbutyl)-1-methylpiperidinium bromide and methylester in liquid medicamentous forms determination